Like Data Interpretation Division

closed 5/25/2016 via Company Press Release

Vela Diagnostics Pte. Ltd., purchased Data Interpretation Division from Lifecode, Inc.

synopsis: Vela Diagnostics announced that it has acquired the data interpretation division of Lifecode Inc., a Foster City, California-based cancer molecular company. The data interpretation products and services from Lifecode will be connected to Vela Diagnostics’ Next-Generation Sequencing Sentosa® SQ Reporter Software.
buyer: Vela Diagnostics Pte. Ltd.
Vela Diagnostics is a worldwide supplier of integrated life sciences and diagnostic solutions that help provide customers with valuable molecular information. It delivers innovative technology and products* that address many of the clinical, technical and economic issues facing laboratories. "
seller: Lifecode, Inc.
Lifecode Inc’s data interpretation service provides access to Lifecode’s data integration framework, interpretation and report generation pipelines. Lifecode is a specialized CLIA certified clinical laboratory focused on the genetic basis of human disease.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2018 via BusinessWire

Illumina, Inc., acquired Edico Genome Inc.

synopsis: Illumina, Inc.  announced that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing. Edico Genome’s DRAGEN Bio-IT Platform uses field programmable gate array technology in conjunction with proprietary software algorithms to reduce both data footprint and time to results.
buyer: Illumina, Inc. (ILMN:$3,556.00)
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. "
target: Edico Genome Inc.
Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting edge solutions that power the genomic revolution. Their vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale and accuracy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/23/2017 via BusinessWire

Omicia, acquired Spiral Genetics

synopsis: Omicia, Inc., a leading provider of clinical genomic data analysis and reporting software, announced that it has acquired Seattle-based Spiral Genetics. Spiral’s advanced tools add multiple variant detection capabilities for next generation sequencing (NGS) to Omicia’s industry-leading software platform.
buyer: Omicia
Clinicians and scientists utilize Omicia’s tools to quickly process and analyze genomic data and ultimately improve patient outcomes. Headquartered in Oakland, California, Omicia was founded by renowned scientists and industry veterans who are pioneers in bioinformatics, genomics and diagnostics. "
target: Spiral Genetics
Headquartered in Seattle, WA, Spiral Genetics is a bioinformatics company that develops high performance software for analyzing next-generation sequencing data. They specialize in large-scale DNA data analysis for medical, pharmaceutical and agricultural research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2016 via BusinessWire

PierianDx, acquired Tute Genomics

synopsis: PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced the acquisition of Tute Genomics, a genomics software company based in Provo, UT. The acquisition furthers PierianDx’s goal to be the most comprehensive, integrated platform to enable personalized medicine for clinical labs.
buyer: PierianDx
Founded in 2011, PierianDx is the leading provider of genomic software. They enable health systems, academic medical centers and commercial labs to deliver patient-specific diagnosis and treatments based on an individual’s DNA. "
target: Tute Genomics
Tute Genomics provides a cloud-based genome informatics solution to help diagnostic labs and health systems process next-generation sequencing data in a secure fashion. Tute is powering the world's genomic knowledge through enterprise informatics, genome interpretation, and clinical insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/4/2015 via BusinessWire

Agilent Technologies Inc., will acquire Cartagenia

synopsis: Agilent Technologies Inc. will acquire Cartagenia, a leading provider of software and services for clinical genetics and molecular pathology labs. Cartagenia provides software solutions for variant assessment and reporting of clinical genomics data from next-generation sequencing and microarrays.
buyer: Agilent Technologies Inc. (A:$4,720.00)
Agilent Technologies Inc. is a global leader in life sciences, diagnostics and applied chemical markets. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. "
target: Cartagenia
Cartagenia helps labs to confidently interpret, report and share genomic variants. Reduce turnaround time, build informed variant assessment pipelines, generate clinical grade lab reports, and manage increasing volumes of data. Bring together CNVs and molecular variation. Use clinical phenotypes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/11/2016 via BNC Analysis

Stryker Corporation, acquired imorphics

synopsis: Stryker Corporation has acquired Imorphics, Ltd. Imorphics was initially a spin out from the world renowned Computer Imaging Department of Manchester University. Its product, EndPoint, is a software environment in which the user can build and use statistical models, as well as view images and perform analysis tasks, such as manual segmentation.
buyer: Stryker Corporation (SYK:$10,062.00)
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. "
target: imorphics
Imorphics, Ltd. provides medical image analysis software tools. Its projects include work on diseases of the musculoskeletal system, the central nervous system, and oncology. The company’s technology is used in clinical trials, and in both clinical and animal research projects.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/18/2019 via BNC Analysis

NVIDIA Corporation, acquired Parabricks

synopsis: Computational technology company Nvidia has acquired sequencing analysis software developer Parabricks. Based in Ann Arbor, Michigan, Parabricks has developed technology that leans on graphics processing units to accelerate the analysis of whole genomes to less than one hour.
buyer: NVIDIA Corporation (NVDA:$10,918.00)
NVIDIA Corporation is the worldwide leader in programmable graphics processor technologies. The Company creates innovative, industry-changing products for computing, consumer electronics, and mobile devices. "
target: Parabricks
Parabricks is a sequencing analysis software developer. Based in Ann Arbor, Michigan, Parabricks has developed technology that leans on graphics processing units to accelerate the analysis of whole genomes to less than one hour.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/27/2016 via BNC Analysis

Venaxis, Inc., will acquire Strand Life Sciences

synopsis: Venaxis, a developer of an in vitro diagnostic test for acute appendicitis, is to acquire Strand Life Sciences, a cancer genomics firm. Strand's entry into healthcare was through software products and services that combine advanced visualization, systems modeling, and scientific insights for enabling biological and health sciences research.
buyer: Venaxis, Inc. (BIOP:$0.01)
Venaxis is a Colorado-based in vitro diagnostic company focused on developing and commercializing its unique multi-biomarker diagnostic test, the APPY1™ Test, which is designed to aid in the identification of patients at low risk for acute appendicitis. "
target: Strand Life Sciences
Strand's entry into healthcare was through software products and services that combine advanced visualization, systems modeling, and scientific insights for enabling biological and health sciences research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2020 via BusinessWire

Riverside Insights, acquired ImPACT Concussion Management

synopsis: Riverside Insights, a provider of educational and clinical assessments and a portfolio company of Alpine Investors, has acquired ImPACT Applications, Inc., a leading provider of research-backed concussion assessments. ImPACT Applications offers the only FDA-cleared neurocognitive evaluation aid with concussion specific indications for ages 12-59.
buyer parent: Alpine Investors, LP
buyer: Riverside Insights
Riverside is a provider of educational and clinical assessments that play a key role in helping individuals elevate their learning potential by providing accurate and reliable data. Riverside is comprised of several iconic, leading brands such as Woodcock-Johnson, the Iowa Assessments, and CogAT. "
target: ImPACT Concussion Management
ImPACT Applications, Inc. is the maker of ImPACT, ImPACT Pediatric, and ImPACT Quick Test, all FDA cleared Class I & II medical devices and software solutions that assist in the screening, assessment, and management of concussion.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/24/2017 via BNC Analysis

ERT, acquired ImageIQ

synopsis: ERT - a provider of clinical trial services - announced the acquisition of ImageIQ, an imaging software and contract research organization and software developer for customized imaging and analysis.
buyer parent: Nordic Capital
buyer: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions. "
target: ImageIQ
ImageIQ is an imaging software and contract research organization and software developer for customized imaging and analysis.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/27/2007 via BNC Analysis

Marine Park Holdings, Inc., merged with NewCardio, Inc.

synopsis: NewCardio, Inc. announced the closing of a share exchange agreement with Marine Park Holdings, Inc. whereby NewCardio is now a public company by way of reverse merger. NewCardio's common stock is currently quoted for trading on the Over the Counter Bulletin Board.
buyer: Marine Park Holdings, Inc.
Marine Park Holdings, Inc. formerly known as: EP Floors, Inc. does not have significant operations. "
target: NewCardio, Inc.
NewCardio is a Silicon Valley based company with the mission of fully developing and commercializing a three dimensional (3D) approach to electrocardiography.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/10/2018 via BusinessWire

Zymergen, acquired Radiant Genomics

synopsis: Zymergen, a molecular technology company, announced the acquisition of Radiant Genomics, a leader in functional metagenomics research. Radiant Genomics has developed a robust industrial platform for natural product and gene discovery that allows scientists to rapidly identify, produce, and test products encoded in the genomes of organisms.
buyer: Zymergen
Zymergen is a molecular technology company ushering in a new age of manufacturing and industrial innovation. Leveraging the power of machine learning, automation, and bioengineering, they discover new molecular products that touch every industry. "
target: Radiant Genomics
Radiant Genomics is a leader in functional metagenomics research. Radiant Genomics has developed a robust industrial platform for natural product and gene discovery that allows scientists to rapidly identify, produce, and test products encoded in the genomes of millions of organisms.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/30/2020 via BNC Analysis

Comet Group, will acquire Object Research Systems, Inc.

synopsis: The Comet Group, a globally leading Swiss technology firm, will acquire Object Research Systems (ORS), a provider of 3D-visualization and analysis solutions for research and industrial applications in Canada. ORS' Dragonfly platform delivers volume rendering and advanced analysis functions. They also offer a powerful medical imaging solution.
buyer: Comet Group (SWX:COTN:$412.18)
The Comet Group is a globally leading Swiss technology firm. Comet develops and produces innovative high-tech components and systems based on x-ray and radio frequency (RF). The group manufactures RF matching networks, RF generators, x-ray modules, x-ray tubes, x-ray systems, and more. "
target: Object Research Systems, Inc.
Object Research Systems (ORS) is a provider of 3D-visualization and analysis solutions for research and industrial applications in Canada. ORS' Dragonfly platform delivers state-of-the-art volume rendering and advanced analysis functions. They also offer a powerful medical imaging solution.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/27/2019 via Company Press Release

Canon Medical System, will acquire Skope Magnetic Resonance Technologies AG

synopsis: Canon Medical Systems, a Japanese subsidiary of Canon that developed and introduced the first Japanese MRI and has been devoting itself to research and development of innovative MRI technologies, has acquired Skope, a Swiss company devoted to providing MRI users with unprecedented imaging quality and performance.
buyer parent: Canon Inc.
buyer: Canon Medical System
Canon Medical Systems developed and introduced the first Japanese MRI in 1983, and has been devoting itself to research and development of innovative MRI technologies such as Pianissimo, Canon Medical’s unique acoustic noise reduction technology, providing extraordinary patient comfort. "
target: Skope Magnetic Resonance Technologies AG
Skope Magnetic Resonance Technologies AG is a Swiss company devoted to providing MRI users with unprecedented imaging quality and performance. Skope’s expertise in MRI sensorics, signal-processing and image reconstruction covers the entire chain from signal acquisition to image generation
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2018 via PR Newswire

Sophia Genetics, acquired Interactive Biosoftware

synopsis: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS), the creators of Alamut®, the most used decision support software for clinical genomic data interpretation. Alamut® is currently deployed in over 450 hospitals.
buyer: Sophia Genetics
Based in Switzerland, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients. "
target: Interactive Biosoftware
Interactive Biosoftware was founded in Rouen, France, by a group of medical and computer scientists focusing on practical software applications for health care and life sciences, particularly in the field of genomics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/14/2018 via BNC Analysis

Flying Brands LTD., acquired Imaging Biometrics

synopsis: Flying Brands, a medical services and software company based in the United Kingdom, has acquired Imaging Biometrics, a company based in Wisconsin that is advancing the field of medical imaging by specializing in the design and manufacture of advanced visualization software solutions using quantitative imaging endpoints/biomarkers.
buyer: Flying Brands LTD.
Flying Brands Limited is a medical services and software company based in the United Kingdom. Their product, Stonechecker, is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention. "
target: Imaging Biometrics
Imaging Biometrics (IB) is based in Wisconsin, USA. It is advancing the field of medical imaging by specializing in the design and manufacture of advanced visualization software solutions using quantitative imaging endpoints/biomarkers.
price ($mm)
$0.76
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2016 via PR Newswire

Zimmer Biomet Holdings, Inc., acquired Clinical Graphics, B.V.

synopsis: Zimmer Biomet Holdings, Inc. announced the strategic acquisition of Clinical Graphics, B.V., a novel imaging company specializing in 3D range-of-motion simulation technology to inform treatment decisions for hip conditions requiring early intervention. Zimmer Biomet plans to integrate the imaging platform to enhance its hip preservation portfolio.
buyer: Zimmer Biomet Holdings, Inc. (ZBH:$7,604.40)
Zimmer Biomet is a global leader in musculoskeletal healthcare. They design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products, bone healing, dental implants; and related surgical products. "
target: Clinical Graphics, B.V.
Clinical Graphics began in 2010 as a spin-off from Delft University of Technology and is headquartered in The Netherlands at technology incubator Yes!Delft. The company enables physicians to see beyond the usual by converting medical scans into 3D motion simulations of patients' anatomy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/4/2016 via BusinessWire

Sectra AB, acquired RxEye AB

synopsis: IT and medical technology company Sectra has acquired the Swedish company RxEye AB, which sells cloud-based IT services for efficient and secure remote viewing of medical images.
buyer: Sectra AB (STO:SECTB:$121.11)
Sectra successfully develops and sells cutting edge solutions and services within the niches medical IT and secure communication. The company’s products are used by customers in 50 countries and sales are conducted directly by Sectra as well as through regional partners. "
target: RxEye AB
RxEye AB sells cloud-based IT services for efficient and secure remote viewing of medical images. The services are used, for example, by radiology, nuclear medicine and pathology departments, as well as by companies that sell teleradiology services.
price ($mm)
rev ($mm)
$1
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
announced 7/16/2012 via PR Newswire

Accuray Incorporated, will acquire Morphormics, Inc.

synopsis: Accuray Incorporated, the premier radiation oncology company, announced that they have signed a definitive agreement to acquire Morphormics, Inc., a privately held company founded by University of North Carolina at Chapel Hill faculty members based on their research in autosegmentation of medical images.
buyer: Accuray Incorporated (ARAY:$409.22)
Accuray Incorporated, based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized innovative treatment solutions that set the standard of care, with the aim of helping patients live longer, better lives. "
target: Morphormics, Inc.
Morphormics, Inc. develops medical imaging software systems that dramatically increase efficiency and success in image-guided medical treatment planning, intervention, and diagnosis. Their image analysis automatically recognizes and extract anatomical structures from 2D, 3D and 4D medical images.
price ($mm)
$4.80*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/27/2018 via PR Newswire

Elekta AB, acquired ACUMYN Inc.

synopsis: Elekta, the leading innovator of equipment and software used to improve and save lives, announced that it has acquired Acumyn, the Canadian quality assurance (QA) company. AQUA, Acumyn's Quality Management System, is a comprehensive software platform that coordinates and centralizes all of the QA tests needed.
buyer: Elekta AB (OM:EKTA B:$1,523.59)
Based in Sweden, Elekta AB is the leading innovator of equipment and software used to improve and save the lives of people with cancer and brain disorders. Elekta treatment solutions and oncology informatics are designed to enhance the delivery of treatment. "
target: ACUMYN Inc.
Acumyn, a medical technology company, created AQUA, a Quality Assurance software that ensures radiotherapy and medical imaging devices will perform reliably to deliver the best possible care to patients. Acumyn is known for their integrated Quality Management System, AQUA.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/25/2016 via Company Press Release

Vela Diagnostics Pte. Ltd., purchased Data Interpretation Division from Lifecode, Inc.

synopsis: Vela Diagnostics announced that it has acquired the data interpretation division of Lifecode Inc., a Foster City, California-based cancer molecular company. The data interpretation products and services from Lifecode will be connected to Vela Diagnostics’ Next-Generation Sequencing Sentosa® SQ Reporter Software.
buyer: Vela Diagnostics Pte. Ltd.
Vela Diagnostics is a worldwide supplier of integrated life sciences and diagnostic solutions that help provide customers with valuable molecular information. It delivers innovative technology and products* that address many of the clinical, technical and economic issues facing laboratories. "
seller: Lifecode, Inc.
Lifecode Inc’s data interpretation service provides access to Lifecode’s data integration framework, interpretation and report generation pipelines. Lifecode is a specialized CLIA certified clinical laboratory focused on the genetic basis of human disease.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/25/2016 via Company Press Release

Vela Diagnostics Pte. Ltd., purchased Data Interpretation Division from Lifecode, Inc.

synopsis: Vela Diagnostics announced that it has acquired the data interpretation division of Lifecode Inc., a Foster City, California-based cancer molecular company. The data interpretation products and services from Lifecode will be connected to Vela Diagnostics’ Next-Generation Sequencing Sentosa® SQ Reporter Software.
buyer: Vela Diagnostics Pte. Ltd.
Vela Diagnostics is a worldwide supplier of integrated life sciences and diagnostic solutions that help provide customers with valuable molecular information. It delivers innovative technology and products* that address many of the clinical, technical and economic issues facing laboratories. "
seller: Lifecode, Inc.
Lifecode Inc’s data interpretation service provides access to Lifecode’s data integration framework, interpretation and report generation pipelines. Lifecode is a specialized CLIA certified clinical laboratory focused on the genetic basis of human disease.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/13/2020 via GlobeNewswire

TelaDoc, Inc., will acquire InTouch Health

synopsis: Teladoc Health, Inc., the global leader in virtual care, will acquire InTouch Health, the leading provider of enterprise telehealth solutions for hospitals and health systems. This acquisition positions Teladoc Health as the partner of choice for health systems seeking a single solution for their entire virtual care strategy.
buyer: TelaDoc, Inc. (TDOC:$716.29)
Teladoc Health is transforming the healthcare experience with a focus on high quality, lower costs, and improved outcomes. Telehealth Satisfaction Study, the integrated services from Teladoc Health include telehealth, expert medical services, AI and analytics, and licensable platform services. "
target parent: Galen Partners
target: InTouch Health
InTouch Health is a telehealth services company that offers healthcare providers a reliable, dedicated cloud-based network and virtual care solutions to efficiently deliver care for a broad array of use cases and healthcare environments.
price ($mm)
$600
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/27/2009 via Reuters

The Carlyle Group, will acquire Broadleaf Co., Ltd.

synopsis: Private equity firm The Carlyle Group announced that it has agreed to purchase Broadleaf Co, a Japanese maker of software for car maintenance facilities. This is the first buyout for Carlyle in Japan since it bought LCD glass maker AvanStrate Inc.
buyer: The Carlyle Group (CG:$1,880.20)
The Carlyle Group is a private global investment firm that originates, structures and acts as lead equity investor in management-led buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. "
target parent: Olympus Corporation
target: Broadleaf Co., Ltd.
Broadleaf Co. is involved in the development, sale, and support of various software packages for the automotive industry, including the Super Frontman automobile maintenance system, administrative system packages for inventory control, customer control, and estimate/sales/billing control.
price ($mm)
$212
rev ($mm)
$181
EBITDA ($mm)
EV / rev
1.2x
EV / EBITDA
closed 1/9/2020 via BusinessWire

Riverside Insights, acquired ImPACT Concussion Management

synopsis: Riverside Insights, a provider of educational and clinical assessments and a portfolio company of Alpine Investors, has acquired ImPACT Applications, Inc., a leading provider of research-backed concussion assessments. ImPACT Applications offers the only FDA-cleared neurocognitive evaluation aid with concussion specific indications for ages 12-59.
buyer parent: Alpine Investors, LP
buyer: Riverside Insights
Riverside is a provider of educational and clinical assessments that play a key role in helping individuals elevate their learning potential by providing accurate and reliable data. Riverside is comprised of several iconic, leading brands such as Woodcock-Johnson, the Iowa Assessments, and CogAT. "
target: ImPACT Concussion Management
ImPACT Applications, Inc. is the maker of ImPACT, ImPACT Pediatric, and ImPACT Quick Test, all FDA cleared Class I & II medical devices and software solutions that assist in the screening, assessment, and management of concussion.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/31/2015 via PR Newswire

Nuvon, Inc. will be merged with Bernoulli Enterprise, Inc.,

synopsis: Cardiopulmonary Corp., a leader in real-time connected healthcare and Nuvon, a leader in medical device integration, interoperability, and clinical intelligence, announced that they have entered into a definitive agreement for Nuvon to merge with Cardiopulmonary Corp.
buyer: Bernoulli Enterprise, Inc.
Cardiopulmonary Corp. is a leader in real-time connected healthcare. Its flagship Bernoulli Enterprise system provides a platform for Medical Device Connectivity, Alarm Management, Virtual ICU and Analytics to enable better outcomes, reduce the cost of care and improve patient/staff satisfaction. "
target: Nuvon, Inc.
Nuvon's mission is to transform medicine by delivering critical Patient Care Data at the point of care. Nuvon's FDA cleared Class I and Class II Medical Device Connectivity and Clinical Intelligence Systems connect and automates the capture of Patient Care Data from medical devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/29/2017 via BNC Analysis

B.Braun Medical Inc., acquired BPMpathway

synopsis: B. Braun, one of the world’s leading manufacturers of medical devices and pharmaceutical products, has acquired 270 Vision Limited (BPMpathway), a UK-based developer of wearable sensor technology. BPMpathway focuses on innovative wearable medical-grade sensors and advanced body data analysis technology for professional sports and medical sectors.
buyer: B.Braun Medical Inc.
B. Braun is a German medical and pharmaceutical device company, which has offices and facilities in more than 50 countries. Its headquarters are located in the small town of Melsungen, in central Germany. "
target: BPMpathway
BPMpathway (270 Vision Limited) is a UK-based developer of wearable sensor technology. Product design and development company BPMpathway focuses on innovative wearable medical-grade sensors and advanced body data analysis technology for professional sports and medical sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2013 via Market Watch

Medtronic, Inc., acquired CardioCom

synopsis: Medtronic, Inc., the global leader in medical technology, announced the closing of the acquisition of Cardiocom, a privately held developer and provider of integrated telehealth and patient services for the management of chronic diseases, in an all cash transaction valued at $200 million.
buyer: Medtronic, Inc. (MDT:$31,062.00)
Medtronic develops and manufactures a wide range of products and therapies with emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions. "
target: CardioCom
Cardiocom is a proven leader in Integrated Clinical Telehealth Services. Cardiocom is a world-class developer, manufacturer and clinical telehealth solutions provider with cutting-edge, yet user-friendly telemonitoring products and services.
price ($mm)
$200
rev ($mm)
$50
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/24/2019 via BusinessWire

ZOLL Medical Corporation, acquired Mobilize RRS LLC

synopsis: ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has acquired Mobilize RRS LLC., a company that markets the Mobilize Rescue Systems app and associated rescue kits. Each Mobilize Rescue Systems product contains medical equipment that pairs with interactive software to help bystanders manage emergencies.
buyer parent: Asahi Kasei Group
buyer: ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. "
target: Mobilize RRS LLC
Mobilize RRS equips bystanders with the resources necessary to respond to medical emergencies. Mobilize RRS’ team of medical professionals, military veterans, and software developers integrated modern medical supplies and an innovative app into a cohesive unit, as Mobilize Rescue Systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/15/2019 via BusinessWire

Tactical Medical Solutions, Inc., acquired TraumaFX

synopsis: Tactical Medical Solutions has acquired TraumaFX Solutions, Inc., a company that is dedicated to developing innovative medical simulation and training technologies that improve survivability of severe injuries on the battlefield and in civilian casualty situations.
buyer parent: Guardian Capital Partners
buyer: Tactical Medical Solutions, Inc.
Tactical Medical Solutions, LLC (TacMed) is a global leader in the development and manufacture of innovative, proprietary pre-hospital medical products and technologies that serve a full spectrum of emergency response environments. "
target parent: ManTech International Corporation
target: TraumaFX
TraumaFX is dedicated to developing innovative medical simulation and training technologies that improve survivability of severe injuries on the battlefield and in civilian casualty situations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/1/2017 via BusinessWire

Clayton, Dubilier & Rice, Inc., Hillhouse Capital, acquired Carestream Dental

synopsis: Carestream Health, working with its parent company, Onex Corporation, has completed the sale of Carestream’s dental digital business to funds managed by Clayton, Dubilier & Rice, a global private investment firm, and CareCapital, a specialist investment platform focused on dental and consumer health in Asia and part of Hillhouse Capital Management.
buyer: Clayton, Dubilier & Rice, Inc.
buyer: Hillhouse Capital
Founded in 1978, Clayton, Dubilier & Rice is a private investment firm. Since inception, CD&R has managed the investment of more than $22 billion in 72 companies representing a broad range of industries with an aggregate transaction value of more than $100 billion. "
target parent: Onex Corporation
target: Carestream Dental
Carestream Dental is the dental digital business of Carestream, an operating company of Onex Corporation. Carestream Dental provides digital imaging equipment and software solutions for dental and oral health professionals. They provide products that are used throughout the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/6/2012 via PR Newswire

CareFusion Corporation, will acquire PhACTs, LLC.

synopsis: CareFusion Corporation announced an agreement to acquire PHACTS, LLC, a Seattle-based technology and consulting company that helps hospital pharmacies better manage inventory, reduce pharmaceutical costs and streamline operations. Terms of the deal were not disclosed.
buyer: CareFusion Corporation (CFN:$3,598.00)
CareFusion Corporation is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. "
target: PhACTs, LLC.
PHACTS was formed to serve Health Systems with multiple hospitals and/or clinics, doctors' offices, surgery centers and other locations, which need to account for and provide medications and pharmacy supplies across their network.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/24/2019 via PR Newswire

3B Scientific GmbH, acquired Cardionics

synopsis: 3B Scientific, a leading German manufacturer and marketer of anatomical and biological education and simulation products for science, healthcare and patient education, announced the acquisition of Cardionics, a leader in Auscultation Simulation products that integrate seamlessly into classroom, clinical, and telehealth applications.
buyer parent: Whitney & Co. LLC
buyer: 3B Scientific GmbH
Headquartered in Germany, 3B Scientific is the world's leading manufacturer of anatomical and biological education and simulation for science, healthcare and patient education. Represented in over 100 countries worldwide, 3B Scientific stands for best quality, best value, and best service. "
target: Cardionics
Cardionics continues to set the pace for auscultation products and services through the development of unique, interactive, and experiential systems that integrate seamlessly into classroom, clinical, and telehealth applications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/18/2020 via Company Press Release

AccuReg Software, acquired Zenig

synopsis: AccuReg, a healthcare technology solutions company offering a full suite of front-end revenue cycle management solutions, has acquired Orlando-based Zenig, an innovator in patient engagement technology solutions that enable touchless check-in, virtual waiting rooms, patient flow and bi-directional communication methods.
buyer: AccuReg Software
AccuReg helps hospitals reduce costs, maximize revenue and enable price transparency and digital patient engagement with its market-leading digital patient access solutions. Its cloud-based integrated suite utilizes automation and intelligence to improve patient experience. "
target: Zenig
Zenig offers patient engagement technology solutions. Zenig humanizes the patient experience by engaging with patients throughout their healthcare journeys. The automated journey begins with appointment reminders.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/13/2020 via Company Press Release

Medtronic, Inc., acquired Digital Surgery

synopsis: Medtronic, the global leader in medical technology, announced the acquisition of Digital Surgery, a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training.
buyer: Medtronic, Inc. (MDT:$31,062.00)
Medtronic is among the world’s largest medical technology, services and solutions companies, alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients. "
target: Digital Surgery
Headquartered in London, England, Digital Surgery’s mission is to digitize surgical protocols using cutting-edge computing and to support the delivery of consistent, data-driven and evidence-based surgical care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/23/2018 via BusinessWire

TransEnterix, Inc., acquired MST Medical Surgery Technologies Ltd.

synopsis: TransEnterix, a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, has acquired MST Medical Surgery Technologies Ltd. (MST), an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment.
buyer: TransEnterix, Inc. (AMEX:TRXC:$14.74)
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery. Their Senhance Surgical Robotic System is a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology. "
target: MST Medical Surgery Technologies Ltd.
MST Medical Surgery Technologies Ltd. (MST) is an Israel medical technology company. MST develops advanced image analysis software to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery (MRCAS).
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2019 via Company Press Release

Sentrics, acquired Silversphere

synopsis: Sentrics, the emerging industry leader that provides integrated technologies to the senior living industry, announced it has acquired Silversphere. Silversphere delivers a suite of interconnected solutions to senior living communities that detect, alert and predict resident needs that help caregivers deliver proactive care and prevent emergencies.
buyer parent: Periscope Equity
buyer: Sentrics
Sentrics is an integrated system of data-driven technology companies enabling greater transparency into the quality of life for residents, providers and families. Sentrics partners with senior living operators to strengthen focus on the total well-being of each resident. "
target: Silversphere
Silversphere is a senior living specific technology company that, for over 70 years, has been dedicated to improving the lives of seniors and their caregivers. Silversphere designs, manufactures, installs, and supports emergency call systems, nurse call systems, resident monitoring, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2004 via BusinessWire

Apogent Technologies, Inc. merged with Fisher Scientific International Inc.,

synopsis: Fisher Scientific International Inc. (NYSE: FSH) today completed its approximately $4.0 billion merger with Apogent Technologies Inc. (formerly trading as NYSE: AOT), providing Fisher Scientific with a $1.1 billion footprint in the high-growth life-science market.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Fisher Scientific International Inc.
Fisher Scientific International, Inc. provides products and services to the scientific research and clinical laboratory markets. It operates in three segments: Scientific Products and Services, Healthcare Products and Services, and Laboratory Workstations. The Scientific Products and Services segmen"
target: Apogent Technologies, Inc.
Apogent Technologies Inc. is a developer and manufacturer of value-added products for the clinical and research markets. Over 80% of the Company's products are consumables. Apogent's operating subsidiaries manufacture most of their products in approximately 80 facilities worldwide. The Company's cu
price ($mm)
$3,991
rev ($mm)
$1,118
EBITDA ($mm)
$313
EV / rev
3.6x
EV / EBITDA
12.7x
closed 1/6/2014 via PR Newswire

Henry Schein, Inc., acquired Julie Owandy Group

synopsis: Henry Schein, Inc., the world's largest provider of healthcare products and services, announced the signing of an agreement to acquire five businesses operating in three European countries from Arseus NV. One of the businesses is the leading dental practice management software company in France, Logiciel Julie.
buyer: Henry Schein, Inc. (HSIC:$13,288.81)
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners. The company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. "
target parent: Arseus NV
target: Julie Owandy Group
Owandy is an international player and is renowned for manufacturing dental imaging solutions and developing imaging and practice management software. Its software is used by around half of the dental practitioners in France.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 8/15/2012 via BNC Analysis

Alere, acquired MedApps, Inc.

synopsis: Waltham, Massachusetts-based Alere acquired wireless remote patient monitoring company MedApps. MedApps is dedicated to developing innovative remote health monitoring solutions that deliver efficient cost-effective connectivity between patient, care provider and electronic medical records.
buyer: Alere (ALR:$2,818.83)
Alere provides disease management services by connecting a unique blend of at-home monitoring technology, patient-empowering education, and nurse-patient relations to improve the daily lives people with heart failure. "
target: MedApps, Inc.
MedApps, Inc. develops mobile health monitoring systems. The company’s solutions link patients, families, and healthcare providers using cellular technology to collect, store, and report health information.
price ($mm)
$22
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/5/2012 via PR Newswire

Varian Medical Systems, Inc., will acquire InfiMed, Inc.

synopsis: Varian Medical Systems, Inc., announced it has reached an agreement to acquire InfiMed, Inc., a privately-owned, leading supplier of workstations including hardware and software for processing diagnostic X-ray images.
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. "
target: InfiMed, Inc.
Since 1983, InfiMed, Inc. has been a developer of digital medical acquisition, image processing, and sensor solutions. These systems are used in hospital Cath Labs, X-ray departments, imaging centers, and trauma centers worldwide.
price ($mm)
$15
rev ($mm)
$15
EBITDA ($mm)
EV / rev
1.0x
EV / EBITDA
announced 5/4/2009 via Company Description

Philips Electronics NV, will acquire Traxtal Inc.

synopsis: Royal Philips Electronics announced that it has acquired Canada-based Traxtal Inc., an innovative medical technology company in the field of minimally-invasive instruments and software for image-guided intervention and therapy.
buyer: Philips Electronics NV (ENXTAM:PHIA:$22,082.52)
Royal Philips Electronics is a global leader in healthcare, lighting and consumer lifestyle, delivering products, services and solutions. The company has medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, home appliances, as well as consumer electronics. "
target: Traxtal Inc.
Traxtal, Inc. engages in the development and manufacture of computer assisted soft tissue navigation technologies. It offers PercuNav system, an image-guided diagnostic and interventional system for various imaging modalities.
price ($mm)
$24
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Data Interpretation Division


read more

Lifecode, Inc.

Edico Genome Inc.

Spiral Genetics

Tute Genomics

Cartagenia

imorphics

Parabricks

Strand Life Sciences

ImPACT Concussion Management

ImageIQ

NewCardio, Inc.

Radiant Genomics

Object Research Systems, Inc.

Skope Magnetic Resonance Technologies AG

Interactive Biosoftware

Imaging Biometrics

Clinical Graphics, B.V.

RxEye AB

Morphormics, Inc.

ACUMYN Inc.

read more

Lifecode, Inc.

read more

Lifecode, Inc.

read more

InTouch Health

Broadleaf Co., Ltd.

ImPACT Concussion Management

Nuvon, Inc.

BPMpathway

CardioCom

Mobilize RRS LLC

TraumaFX

Carestream Dental

PhACTs, LLC.

Cardionics

Zenig

Digital Surgery

MST Medical Surgery Technologies Ltd.

Silversphere

Apogent Technologies, Inc.

Julie Owandy Group

MedApps, Inc.

InfiMed, Inc.

Traxtal Inc.

Geography
Matching Companies
Ticker: STO:SECTB
 
 
 
 
 
 
 
 
Sectra AB
Sectra AB
Sectra successfully develops and sells cutting edge solutions and services within the niches medical IT and secure communication. The company’s products are used by customers in 50 countries and sales are conducted directly by Sectra as well as through regional partners.
year
2015
rev ($mm)
$121.11
EBITDA ($mm)
$19.82
EBIT ($mm)
$16.26
Net Income ($mm)
$13.69
Employees
603
  • drill down
  • watch
Ticker: GS:MTLS
 
 
 
 
 
 
 
 
Materialise Dental N.V.
Materialise Dental N.V.
Materialise Dental offers planning and simulation software tools under the SimPlant brand. These tools enable implantologists and oral surgeons to scientifically plan dental implant surgery on an interactive basis.
year
2014
rev ($mm)
$86.16
EBITDA ($mm)
$5.18
EBIT ($mm)
$0.35
Net Income ($mm)
$2.18
Employees
958
  • drill down
  • watch
Ticker: VAR
 
 
 
 
 
 
 
 
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
Varain Medical Systems produces tools that harness the power of X-ray energy to benefit humankind. They have made developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing.
year
2018
rev ($mm)
$2,888.20
EBITDA ($mm)
$597.60
EBIT ($mm)
$525.70
Net Income ($mm)
$143.20
Employees
6600
  • drill down
  • watch
Ticker: DXCM
 
 
 
 
 
 
 
 
Dexcom, Inc.
Dexcom, Inc.
DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare providers.
year
2018
rev ($mm)
$832.50
EBITDA ($mm)
($2.90)
EBIT ($mm)
($24.10)
Net Income ($mm)
Employees
2290
  • drill down
  • watch
Ticker: ICAD
 
 
 
 
 
 
 
 
iCAD, Inc.
iCAD, Inc.
iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster. iCAD offers a range of computer aided detection (CAD) solutions to support rapid detection of breast, prostate and colorectal cancers.
year
2015
rev ($mm)
$47.24
EBITDA ($mm)
$5.53
EBIT ($mm)
$1.33
Net Income ($mm)
Employees
143
  • drill down
  • watch
Ticker: CERN
 
 
 
 
 
 
 
 
Cerner Corporation
Cerner Corporation
Cerner's health information technologies connect people, information, and systems. Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations.
year
2020
rev ($mm)
$5,714.46
EBITDA ($mm)
$1,168.86
EBIT ($mm)
$707.10
Net Income ($mm)
$510.39
Employees
27400
  • drill down
  • watch
Ticker: 300253
 
 
 
 
 
 
 
 
Shanghai Kingstar Winning Software Co., Ltd.
Shanghai Kingstar Winning Software is principally engaged in the development of medical software, the provision of technology services and the distribution of hardware products. They primarily offer software, including hospital information systems and public health information management systems.
year
2015
rev ($mm)
$98.42
EBITDA ($mm)
$14.01
EBIT ($mm)
$12.72
Net Income ($mm)
$21.57
Employees
454
  • drill down
  • watch
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: POAI
 
 
 
 
 
 
 
 
Predictive Oncology Inc.
Predictive Oncology Inc.
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery. Predictive Oncology operates through five segments which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe.
year
2019
rev ($mm)
$1.38
EBITDA ($mm)
($13.26)
EBIT ($mm)
($13.71)
Net Income ($mm)
Employees
24
  • drill down
  • watch
Ticker: MDRX
 
 
 
 
 
 
 
 
Allscripts
Allscripts
Allscripts is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The company's unique solutions inform, connect and transform healthcare, delivering improved care at lower cost.
year
2020
rev ($mm)
$1,718.10
EBITDA ($mm)
$70.02
EBIT ($mm)
($3.04)
Net Income ($mm)
Employees
9600
  • drill down
  • watch
Ticker: HAE
 
 
 
 
 
 
 
 
Haemonetics Corporation
Haemonetics Corporation
Haemonetics is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions. Their technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.
year
2020
rev ($mm)
$988.48
EBITDA ($mm)
$266.02
EBIT ($mm)
$173.83
Net Income ($mm)
$76.53
Employees
3004
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2020
rev ($mm)
$906.40
EBITDA ($mm)
$100.91
EBIT ($mm)
$61.95
Net Income ($mm)
$49.09
Employees
2780
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2019
rev ($mm)
$879.35
EBITDA ($mm)
$200.48
EBIT ($mm)
$134.28
Net Income ($mm)
$82.69
Employees
5171
  • drill down
  • watch
Ticker: QSII
 
 
 
 
 
 
 
 
Quality Systems, Inc.
Quality Systems, Inc.
Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices.
year
2015
rev ($mm)
$499.35
EBITDA ($mm)
$57.19
EBIT ($mm)
$44.23
Net Income ($mm)
$32.10
Employees
2927
  • drill down
  • watch
Ticker: BIO
 
 
 
 
 
 
 
 
Bio-Rad Laboratories
Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. is a manufacturer of products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California
year
2019
rev ($mm)
$2,311.66
EBITDA ($mm)
$387.06
EBIT ($mm)
$252.86
Net Income ($mm)
$1,758.68
Employees
8120
  • drill down
  • watch
Ticker: ENXTPA:DIM
 
 
 
 
 
 
 
 
Sartorius AG
Sartorius AG
Sartorius is a international pharmaceutical and laboratory equipment supplier. With their innovative products and services, they are helping their customers across the entire globe to implement their complex and quality-critical biomanufacturing and laboratory processes reliably and economically.
year
2016
rev ($mm)
$1,121.72
EBITDA ($mm)
$299.20
EBIT ($mm)
$257.20
Net Income ($mm)
$163.92
Employees
4590
  • drill down
  • watch
Ticker: BIOP
 
 
 
 
 
 
 
 
Riot Blockchain
Riot Blockchain uses its expertise and network to build and support blockchain technology companies. It is establishing an Advisory Board with technical experience intending to become a leading authority and supporter of blockchain, while providing investment exposure to the blockchain ecosystem.
year
2017
rev ($mm)
$0.01
EBITDA ($mm)
($5.25)
EBIT ($mm)
($5.49)
Net Income ($mm)
Employees
8
  • drill down
  • watch
Ticker: MDT
 
 
 
 
 
 
 
 
Medtronic, Inc.
Medtronic, Inc.
Medtronic develops and manufactures a wide range of products and therapies with emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions.
year
2020
rev ($mm)
$31,062.00
EBITDA ($mm)
$9,558.00
EBIT ($mm)
$7,097.00
Net Income ($mm)
$5,408.00
Employees
90000
  • drill down
  • watch
Ticker: ZBH
 
 
 
 
 
 
 
 
Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc.
Zimmer Biomet is a global leader in musculoskeletal healthcare. They design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products, bone healing, dental implants; and related surgical products.
year
2016
rev ($mm)
$7,604.40
EBITDA ($mm)
$2,722.40
EBIT ($mm)
$1,650.80
Net Income ($mm)
$363.30
Employees
17500
  • drill down
  • watch
Ticker: TSE:7733
 
 
 
 
 
 
 
 
Olympus Corporation
Olympus Corporation
Olympus is a global precision technology, designing and delivering innovative solutions in its core business areas of Medical and Surgical Products, Scientific Solutions, and Cameras and Audio Products. Olympus contributes to society every day by making people's lives healthier and safer.
year
2017
rev ($mm)
$6,752.07
EBITDA ($mm)
$1,157.58
EBIT ($mm)
$701.40
Net Income ($mm)
$755.08
Employees
34687
  • drill down
  • watch
Ticker: LSE:SN
 
 
 
 
 
 
 
 
Smith & Nephew, Inc.
Smith & Nephew, Inc.
Smith & Nephew is a global medical technology business. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 14,000 employees and a presence in more than 100 countries.
year
2019
rev ($mm)
$5,138.00
EBITDA ($mm)
$1,358.00
EBIT ($mm)
$955.00
Net Income ($mm)
$600.00
Employees
17500
  • drill down
  • watch
Ticker: CMD
 
 
 
 
 
 
 
 
Cantel Medical Corp.
Cantel Medical Corp.
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.
year
2018
rev ($mm)
$823.42
EBITDA ($mm)
$159.88
EBIT ($mm)
$127.34
Net Income ($mm)
$89.93
Employees
2337
  • drill down
  • watch
Ticker: MR
 
 
 
 
 
 
 
 
Mindray Medical International Limited
Mindray Medical International Limited
Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets.
year
2010
rev ($mm)
$704.31
EBITDA ($mm)
$182.73
EBIT ($mm)
$156.51
Net Income ($mm)
$155.47
Employees
6400
  • drill down
  • watch
Ticker: GMED
 
 
 
 
 
 
 
 
Globus Medical
Globus Medical
Globus Medical, Inc. is a leading medical device manufacturer and is driving significant technological advancements across a complete suite of spinal products.
year
2018
rev ($mm)
$675.57
EBITDA ($mm)
$214.47
EBIT ($mm)
$176.10
Net Income ($mm)
$134.48
Employees
1500
  • drill down
  • watch
Ticker: TNDM
 
 
 
 
 
 
 
 
Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc.
Tandem Diabetes Care is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology.
year
2020
rev ($mm)
$394.24
EBITDA ($mm)
($12.83)
EBIT ($mm)
($19.30)
Net Income ($mm)
Employees
1043
  • drill down
  • watch
Ticker: NYSE:PEN
 
 
 
 
 
 
 
 
Penumbra, Inc.
Penumbra, Inc.
Penumbra, Inc., headquartered in Alameda, Calif., is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs.
year
2018
rev ($mm)
$392.30
EBITDA ($mm)
$24.01
EBIT ($mm)
$18.70
Net Income ($mm)
$28.19
Employees
1700
  • drill down
  • watch
Ticker: ILMN
 
 
 
 
 
 
 
 
Illumina, Inc.
Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets.
year
2020
rev ($mm)
$3,556.00
EBITDA ($mm)
$1,198.00
EBIT ($mm)
$1,013.00
Net Income ($mm)
$942.00
Employees
7700
  • drill down
  • watch
Ticker: BRKR
 
 
 
 
 
 
 
 
Bruker Corporation
Bruker Corporation
Bruker Corporation is a global manufacturer of high-end analytical instruments used within the academic & government, pharma/biotech, clinical diagnostic, and industrial markets. It operates in the life science tools and diagnostic indsutry.
year
2018
rev ($mm)
$1,925.30
EBITDA ($mm)
$347.10
EBIT ($mm)
$279.00
Net Income ($mm)
$183.50
Employees
6870
  • drill down
  • watch
Ticker: ASX:SFP
 
 
 
 
 
 
 
 
Safety Medical Products Ltd
Safety Medical Products Limited has various patents and registered trademarks associated with the SecureTouch syringe in regions and countries including Europe, the United States of America, Africa, Australia and New Zealand.
year
2013
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.77)
Net Income ($mm)
Employees
  • drill down
  • watch